1. Home
  2. IVA vs CURI Comparison

IVA vs CURI Comparison

Compare IVA & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • CURI
  • Stock Information
  • Founded
  • IVA 2011
  • CURI 2015
  • Country
  • IVA France
  • CURI United States
  • Employees
  • IVA N/A
  • CURI N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • CURI Movies/Entertainment
  • Sector
  • IVA Health Care
  • CURI Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • CURI Nasdaq
  • Market Cap
  • IVA 117.3M
  • CURI 100.4M
  • IPO Year
  • IVA 2020
  • CURI N/A
  • Fundamental
  • Price
  • IVA $2.35
  • CURI $1.54
  • Analyst Decision
  • IVA Strong Buy
  • CURI Strong Buy
  • Analyst Count
  • IVA 4
  • CURI 1
  • Target Price
  • IVA $13.25
  • CURI $3.00
  • AVG Volume (30 Days)
  • IVA 9.3K
  • CURI 168.1K
  • Earning Date
  • IVA 09-25-2024
  • CURI 11-06-2024
  • Dividend Yield
  • IVA N/A
  • CURI 6.49%
  • EPS Growth
  • IVA N/A
  • CURI N/A
  • EPS
  • IVA N/A
  • CURI N/A
  • Revenue
  • IVA $20,652,523.00
  • CURI $51,775,000.00
  • Revenue This Year
  • IVA N/A
  • CURI N/A
  • Revenue Next Year
  • IVA $361.78
  • CURI $9.18
  • P/E Ratio
  • IVA N/A
  • CURI N/A
  • Revenue Growth
  • IVA N/A
  • CURI N/A
  • 52 Week Low
  • IVA $1.53
  • CURI $0.45
  • 52 Week High
  • IVA $4.75
  • CURI $3.00
  • Technical
  • Relative Strength Index (RSI)
  • IVA 36.64
  • CURI 37.16
  • Support Level
  • IVA $2.22
  • CURI $1.47
  • Resistance Level
  • IVA $2.39
  • CURI $1.72
  • Average True Range (ATR)
  • IVA 0.10
  • CURI 0.09
  • MACD
  • IVA -0.03
  • CURI -0.01
  • Stochastic Oscillator
  • IVA 24.76
  • CURI 18.42

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

Share on Social Networks: